GLICLAZIDE 80mg

Non-insulin dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.

Pharmacotherapeutic group: sulfonamides, urea derivatives.

Gliclazide is one of a group of medicines called sulfonylureas. It is an oral hypoglycaemic medicine (blood sugar lowering drug). Gliclazide is used to keep blood sugar at the correct level in adults with non-insulin dependent diabetes when it is not controlled by diet, physical exercise and weight loss alone.

Please refer to the instructions on the prescription established by your medical doctor.

Gliclazide Tablets should be taken orally with food, either with breakfast or the first main meal of the day. The usual dosage is as follows:

• Adults and Elderly: The usual starting dose is 40 to 80mg (½ or 1 tablet) daily, adjusted according to your response, up to a maximum of 320mg (four tablets) daily. Up to 160mg (two tablets) can be taken at one time. Your starting dose will be reduced if you are elderly or have liver or kidney problems.
  If a combination therapy of Gliclazide with metformin, an alpha glucosidase inhibitor, a thiazolidinedione, a dipeptidyl peptidase-4 inhibitor, a GLP-1 receptor agonist or insulin is initiated, your doctor will determine the proper dose of each medicine individually for you. If you notice that your blood sugar levels are high although you are taking the medicine as prescribed, you should contact your doctor or pharmacist.
• Children: Gliclazide is not recommended for use in children